210 related articles for article (PubMed ID: 38881904)
21. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
Front Immunol; 2021; 12():645242. PubMed ID: 33815400
[TBL] [Abstract][Full Text] [Related]
22. Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy.
Zou W; Green DR
Cell Metab; 2023 Jul; 35(7):1101-1113. PubMed ID: 37390822
[TBL] [Abstract][Full Text] [Related]
23. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
24. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
Bader JE; Voss K; Rathmell JC
Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
[TBL] [Abstract][Full Text] [Related]
25. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
Li X; Xiang Y; Li F; Yin C; Li B; Ke X
Front Immunol; 2019; 10():2293. PubMed ID: 31616443
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism.
De Rosa V; Di Rella F; Di Giacomo A; Matarese G
Cytokine Growth Factor Rev; 2017 Jun; 35():15-25. PubMed ID: 28442214
[TBL] [Abstract][Full Text] [Related]
27. Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma.
Castella B; Riganti C; Massaia M
Front Biosci (Landmark Ed); 2020 Jan; 25(1):69-105. PubMed ID: 31585878
[TBL] [Abstract][Full Text] [Related]
28. Vascular Microenvironment, Tumor Immunity and Immunotherapy.
Lamplugh Z; Fan Y
Front Immunol; 2021; 12():811485. PubMed ID: 34987525
[TBL] [Abstract][Full Text] [Related]
29. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
Zhang M; Kim JA; Huang AY
Front Immunol; 2018; 9():341. PubMed ID: 29535722
[TBL] [Abstract][Full Text] [Related]
30. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
31. Metabolic interventions: A new insight into the cancer immunotherapy.
Yu T; Dong T; Eyvani H; Fang Y; Wang X; Zhang X; Lu X
Arch Biochem Biophys; 2021 Jan; 697():108659. PubMed ID: 33144083
[TBL] [Abstract][Full Text] [Related]
32. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells.
Sullivan PM; Reed SJ; Kalia V; Sarkar S
Front Immunol; 2021; 12():706150. PubMed ID: 34867942
[TBL] [Abstract][Full Text] [Related]
33. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
Rivadeneira DB; Delgoffe GM
Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy.
Peng X; He Y; Huang J; Tao Y; Liu S
Front Immunol; 2021; 12():613492. PubMed ID: 33732237
[TBL] [Abstract][Full Text] [Related]
35. The tumour glyco-code as a novel immune checkpoint for immunotherapy.
RodrÍguez E; Schetters STT; van Kooyk Y
Nat Rev Immunol; 2018 Mar; 18(3):204-211. PubMed ID: 29398707
[TBL] [Abstract][Full Text] [Related]
36. [Metabolic Competition in Tumor Microenvironment].
Eikawa S; Udono H
Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
[TBL] [Abstract][Full Text] [Related]
37. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma.
Ramachandran I; Lowther DE; Dryer-Minnerly R; Wang R; Fayngerts S; Nunez D; Betts G; Bath N; Tipping AJ; Melchiori L; Navenot JM; Glod J; Mackall CL; D'Angelo SP; Araujo DM; Chow WA; Demetri GD; Druta M; Van Tine BA; Grupp SA; Abdul Razak AR; Wilky B; Iyengar M; Trivedi T; Winkle EV; Chagin K; Amado R; Binder GK; Basu S
J Immunother Cancer; 2019 Oct; 7(1):276. PubMed ID: 31651363
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy and tumor microenvironment.
Tang H; Qiao J; Fu YX
Cancer Lett; 2016 Jan; 370(1):85-90. PubMed ID: 26477683
[TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]